KORU Medical Systems (KRMD) Cash from Investing Activities (2010 - 2026)
KORU Medical Systems (KRMD) posted quarterly Cash from Investing Activities of -$89885.0 for Q1 2026, up 79.88% year-over-year from -$49968.3 in Q1 2025, and up 78.68% quarter-over-quarter from -$421655.0 in Q4 2025.
KORU Medical Systems (KRMD) Cash from Investing Activities (2010 - 2026) Analysis & Trends
KORU Medical Systems (KRMD) has reported Cash from Investing Activities for 12 consecutive years, with -$89885.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 79.88% year-over-year to -$89885.0; the TTM figure through Mar 2026 stood at -$592837.0 (up 64.0% YoY), while the FY2025 annual figure was -$949790.0, up 28.75% from the prior year.
- Cash from Investing Activities rose to -$89885.0 in Q1 2026 per KRMD's latest filing, from -$421655.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $50738.0 in Q4 2024 and bottomed at -$1.2 million in Q2 2022.
- Historically, Cash from Investing Activities has averaged -$352287.2 across 5 years, with a median of -$213665.0 in 2023.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities plunged 1711.48% — and 2024, when it jumped 124.35%.
- KORU Medical Systems' Cash from Investing Activities stood at -$223872.0 in 2022, then climbed by 6.92% to -$208388.0 in 2023, then surged by 124.35% to $50738.0 in 2024, then slumped by 931.04% to -$421655.0 in 2025, then jumped by 78.68% to -$89885.0 in 2026.
- Business Quant data shows KRMD's Cash from Investing Activities at -$89885.0 in Q1 2026, -$421655.0 in Q4 2025, and -$52483.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | KORU Medical Systems | 149.08 Mn | 140.78 Mn | 7.85 Mn | -577,367.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -577,367.00 |
| Jun 30, 2026 | -577,367.00 |
| Mar 31, 2026 | -89,885.00 |
| Mar 31, 2026 | -89,885.00 |
| Dec 31, 2025 | -421,655.00 |
| Dec 31, 2025 | -421,655.00 |
| Sep 30, 2025 | -52,483.00 |
| Sep 30, 2025 | -52,483.00 |
| Jun 30, 2025 | -28,814.00 |
| Jun 30, 2025 | -28,814.00 |
| Mar 31, 2025 | -446,838.00 |
| Mar 31, 2025 | -446,838.00 |
| Dec 31, 2024 | 50,738.00 |
| Dec 31, 2024 | 50,738.00 |
| Sep 30, 2024 | -1.10 Mn |
| Sep 30, 2024 | -1.10 Mn |
| Jun 30, 2024 | -148,500.00 |
| Jun 30, 2024 | -148,500.00 |
| Mar 31, 2024 | -133,083.00 |
| Mar 31, 2024 | -133,083.00 |